PLAY PODCASTS
Recent Advances in PBC Management
Episode 418

Recent Advances in PBC Management

Listen as Christopher L. Bowlus, MD, discusses recent advances in the management of primary biliary cholangitis (PBC), including treatment goals and the latest clinical trial data on recently approved medications .

Decera Clinical Education Infectious Disease Podcast · Christopher L. Bowlus MD

December 13, 20248m 46s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Christopher L. Bowlus, MD, discusses recent advances in the management of primary biliary cholangitis (PBC), including:

  • Treatment goals
  • Use of PPAR agonists for the treatment of PBC
  • Clinical trial results for elafibranor (ELATIVE), seladelpar (RESPONSE), and bezafibrate (BEZURSO)

Presenter:

Christopher L. Bowlus, MD
Lena Valente Professor and Chief
Division of Gastroenterology and Hepatology
University of California Davis School of Medicine
Sacramento, California

Link to full program: 
https://bit.ly/41tvSDu

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

bezafibrateocaobeticholic acidelafibranorudcaitchingseladelparursodeoxycholic acidprimary biliary cholangitisbezursoenhanceelativeresponsepbc